CATEGORY: GSK PLC

Brief: GlaxoSmithKline’s 2017 Q1 Result

GlaxoSmithKline today released Unaudited  Interim Financial Statements for the three months ended 31 March 2017.   Revenue N’million Q1...


Alert: Glaxosmithkline Reports N2.4 billion Profit (2016 FY)

GSK today released audited results for the financial year ended 31 December 2016.   Revenue N’million FY 2016| N14,385...


CEO of Suntory Ltd,  Makes First Comment Since Buying Ribena and Lucozade

Suntory Beverage and Food Nigeria recently acquired the distribution business of popular beverage brands, Lucozade and Ribena from GSK...



ALERT: GlaxoSmithKline Nigeria Plc Release 2016 Third Quarter Earnings

GSK Nigeria Plc released its 2016 result for the nine months ended 30 September 2016 ; See below    ...


Quote: Why We Sold Our Ribena and Drinks Business – GSK

GSK Regional Head for Asia, Middle East & Africa, Mr. Zubair Ahmed explains why they divested from their drinks...


GSK Nigeria Completes Divestment of Drinks Bottling Business To Suntory BFN Ltd.

Glaxosmithkline Consumer Nigeria Plc has completed the divestment of its drinks bottling and distribution business to Suntory Beverage &...



GSK Declares 60 Kobo Special Dividend to Shareholders

GlaxoSmithKline Consumer Goods Nigeria Plc has announced the declaration of a special dividend of 60 Kobo per share to...


We Listened In On GSK Investor Conference Call And Here Is What We Discovered

GlaxoSmithKline Consumer Nigeria Plc (GSK) held an investor conference call yesterday to discuss the proposed disposal of its drinks...


Should Shareholders Be Worried About GSK’s Future?

Shareholders could be in the hook for lengthy bearish...


GSK Nigeria Has Moved One Step Closer Towards Spinning Off Ribena & Lucozade Boost

GlaxoSmithKline Consumer Nigeria Plc has announced that its Board of Directors have approved the binding offer to sell its...


GSK Gets Squeezed By Economic Doldrums As Earnings Slump

GlaxoSmithKline Consumer Nigeria Plc, the publicly traded local unit of the U.K.’s biggest drug maker has been hard squeezed...


GlaxoSmithkline Pre-tax Profit Down 57% To N1.1 billion, Proposes Dividend of 30 Kobo

Glaxosmithkline released its financial results for the year ended 31st December 2015. The results showed that revenue increased marginally...


“Extranormal” : Rencap Explains Why GSK Nigeria Is A Strong Buy

On 25 January 2016, GlaxoSmithKline Consumer Nigeria Plc (GSK Nigeria) received a non-binding offer from Suntory Beverages & Foods...


GSK Nigeria Has Received An Offer To Sell Its Ribena & Lucozade Businesses

Reuters reports GSK has been made an offer to sell its bottling and distribution drinks businesses. The offer to...


[Corporate Action] GlaxoSmithKline’s Profits Drops By 74% to N485 million In Q3’2015

GlaxoSmithKline Nigeria Plc released its financial results for nine months ended September 2015. The result showed that revenue declined...


Here Is Why Renaissance Capital Switched GSK & 7up to a BUY

We assess the bottom of the pyramid (BOP) consumer in Nigeria and analyse which companies both private and public...


Nigeria Drug makers capitulate as margins slump

Drug makers in Africa largest economy have capitulated to huge production costs that left these companies with low profit...


[YEAR LOW] These 7 Blue Chip Nigerian Stocks Just Got Bloodied

This week ended with yet another sell-off as stocks shed a whopping N900 billion in one week. A major reason for...


2014 H1: GSK Post Disappointing 40% Drop In Pre-Tax Profits

GSK Plc released its 2014 H1 results declaring a revenue of N15.6billion and a 12% increase from the N13.9billion...